These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 19931262

  • 1. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
    Targownik LE, Lix LM, Leung S, Leslie WD.
    Gastroenterology; 2010 Mar; 138(3):896-904. PubMed ID: 19931262
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
    Lyu B, Hansen KE, Jorgenson MR, Astor BC.
    Am J Nephrol; 2020 Mar; 51(6):433-441. PubMed ID: 32485707
    [Abstract] [Full Text] [Related]

  • 5. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors.
    Bahtiri E, Islami H, Hoxha R, Qorraj-Bytyqi H, Rexhepi S, Hoti K, Thaçi K, Thaçi S, Karakulak Ç.
    J Bone Miner Metab; 2016 Sep; 34(5):571-9. PubMed ID: 26209167
    [Abstract] [Full Text] [Related]

  • 6. Trochanteric hip fracture: strong association with spinal trabecular bone mineral density measured with quantitative CT.
    Lang TF, Augat P, Lane NE, Genant HK.
    Radiology; 1998 Nov; 209(2):525-30. PubMed ID: 9807584
    [Abstract] [Full Text] [Related]

  • 7. Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Jamal SA, Goltzman D, Hanley DA, Papaioannou A, Prior JC, Josse RG.
    Osteoporos Int; 2009 May; 20(5):737-44. PubMed ID: 18800179
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density and vertebral fractures in men.
    Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y, Rohmer V, Basle MF, Audran M.
    Osteoporos Int; 1999 May; 10(4):265-70. PubMed ID: 10692973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Role of osteoporosis in trauma diagnostics].
    Bitterling H, Vogel T, Dobler T, Mutschler W, Pfeifer KJ, Reiser M, Eibel R.
    Rofo; 2005 Dec; 177(12):1663-9. PubMed ID: 16333789
    [Abstract] [Full Text] [Related]

  • 11. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
    Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, Chen Z.
    Arch Intern Med; 2010 May 10; 170(9):765-71. PubMed ID: 20458083
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.
    Targownik LE, Goertzen AL, Luo Y, Leslie WD.
    Am J Gastroenterol; 2017 Jan 10; 112(1):95-101. PubMed ID: 27845341
    [Abstract] [Full Text] [Related]

  • 13. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM, Yang SH, Liang CC, Huang HK.
    Osteoporos Int; 2018 Jan 10; 29(1):153-162. PubMed ID: 29032384
    [Abstract] [Full Text] [Related]

  • 14. Discordantly high spinal bone mineral density values in patients with adult lumbar scoliosis.
    Pappou IP, Girardi FP, Sandhu HS, Parvataneni HK, Cammisa FP, Schneider R, Frelinghuysen P, Lane JM.
    Spine (Phila Pa 1976); 2006 Jun 15; 31(14):1614-20. PubMed ID: 16778698
    [Abstract] [Full Text] [Related]

  • 15. Cannabis use and bone mineral density: NHANES 2007-2010.
    Bourne D, Plinke W, Hooker ER, Nielson CM.
    Arch Osteoporos; 2017 Dec 15; 12(1):29. PubMed ID: 28286929
    [Abstract] [Full Text] [Related]

  • 16. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
    Adams AL, Black MH, Zhang JL, Shi JM, Jacobsen SJ.
    Ann Epidemiol; 2014 Apr 15; 24(4):286-90. PubMed ID: 24507954
    [Abstract] [Full Text] [Related]

  • 17. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis.
    Targownik LE, Bernstein CN, Nugent Z, Leslie WD.
    Clin Gastroenterol Hepatol; 2013 Mar 15; 11(3):278-85. PubMed ID: 23103821
    [Abstract] [Full Text] [Related]

  • 18. Fractal analysis of radiographic trabecular bone texture and bone mineral density: two complementary parameters related to osteoporotic fractures.
    Benhamou CL, Poupon S, Lespessailles E, Loiseau S, Jennane R, Siroux V, Ohley W, Pothuaud L.
    J Bone Miner Res; 2001 Apr 15; 16(4):697-704. PubMed ID: 11315997
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study.
    Solomon DH, Diem SJ, Ruppert K, Lian YJ, Liu CC, Wohlfart A, Greendale GA, Finkelstein JS.
    J Bone Miner Res; 2015 Feb 15; 30(2):232-9. PubMed ID: 25156141
    [Abstract] [Full Text] [Related]

  • 20. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR, Targownik LE, Leslie WD.
    Maturitas; 2009 Sep 20; 64(1):9-13. PubMed ID: 19674854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.